drugset / Trial / NCT00004396
Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute Porphyrias
Phase 2
Completed
32 enrolled
National Center for Research Resources (NCRR)
University of Texas · collab
Treatment
Summary
OBJECTIVES: I. Compare the efficacy of heme arginate, singly or in combination with tin mesoporphyrin, in lowering porphyrin precursors in patients with asymptomatic acute intermittent porphyria. II. Evaluate and compare the safety and tolerability of these treatment regimens in this patient population.
Timeline
- Start
- 1997-09
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | heme arginate | Small molecule | — | Intravenous |
| Subject | stannsoporfin | Small molecule | — | Intravenous |